Protective Antibody Levels Against Hepatitis B among Serodiagnosed Syphilis Cases: Need to Integrate National Control Programs with Immunization Guidelines?

Background: The intersecting routes of transmission in conjunction with hepatocyte injury caused by hepatotropic viruses and Treponema pallidum independently add to the importance of hepatitis B virus (HBV) seroprotection in syphilis. Furthermore, the deficit in the clinical suspicion and stigma ass...

Full description

Saved in:
Bibliographic Details
Main Authors: Bineeta Kashyap, Rituparna Saha, Narendra Pal Singh, Krishna Singha
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Indian Journal of Medical Specialities
Subjects:
Online Access:https://journals.lww.com/10.4103/injms.injms_103_20
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849224503265067008
author Bineeta Kashyap
Rituparna Saha
Narendra Pal Singh
Krishna Singha
author_facet Bineeta Kashyap
Rituparna Saha
Narendra Pal Singh
Krishna Singha
author_sort Bineeta Kashyap
collection DOAJ
description Background: The intersecting routes of transmission in conjunction with hepatocyte injury caused by hepatotropic viruses and Treponema pallidum independently add to the importance of hepatitis B virus (HBV) seroprotection in syphilis. Furthermore, the deficit in the clinical suspicion and stigma associated could at least be partially responsible for the underdiagnosis of syphilitic hepatitis, which is caused by the effect of T. pallidum on hepatocytes. Materials and Methods: Sera from eighty patients, serologically confirmed for syphilis by conventional algorithm, were included in the study. Levels of anti-HBs antibody were determined by ELISA for all serologically confirmed cases of syphilis. Results: Majority of the patients who tested positive for syphilis as per conventional algorithm, hailed from antiretroviral therapy (ART) and sexually transmitted infection (STI) clinics. Levels of anti-HBs antibody of all the patients were found to be below 10 mIU/ml. Conclusion: The absence of protective levels of anti-HBs antibody among all the patients in the study group, despite the inclusion of HBV vaccination in the national immunization program and proximity to tertiary health-care facilities, underscores the pressing need to reinforce and revise our approach to immunization. High-risk groups, such as ART and STI clinic attendees, solicit further enforcement of accelerated immunization strategies in excess to existing dosing schedules.
format Article
id doaj-art-3ef3853274dd456dbec1ccddcb8baffa
institution Kabale University
issn 0976-2884
0976-2892
language English
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Medical Specialities
spelling doaj-art-3ef3853274dd456dbec1ccddcb8baffa2025-08-25T08:33:44ZengWolters Kluwer Medknow PublicationsIndian Journal of Medical Specialities0976-28840976-28922021-01-01121151810.4103/injms.injms_103_20Protective Antibody Levels Against Hepatitis B among Serodiagnosed Syphilis Cases: Need to Integrate National Control Programs with Immunization Guidelines?Bineeta KashyapRituparna SahaNarendra Pal SinghKrishna SinghaBackground: The intersecting routes of transmission in conjunction with hepatocyte injury caused by hepatotropic viruses and Treponema pallidum independently add to the importance of hepatitis B virus (HBV) seroprotection in syphilis. Furthermore, the deficit in the clinical suspicion and stigma associated could at least be partially responsible for the underdiagnosis of syphilitic hepatitis, which is caused by the effect of T. pallidum on hepatocytes. Materials and Methods: Sera from eighty patients, serologically confirmed for syphilis by conventional algorithm, were included in the study. Levels of anti-HBs antibody were determined by ELISA for all serologically confirmed cases of syphilis. Results: Majority of the patients who tested positive for syphilis as per conventional algorithm, hailed from antiretroviral therapy (ART) and sexually transmitted infection (STI) clinics. Levels of anti-HBs antibody of all the patients were found to be below 10 mIU/ml. Conclusion: The absence of protective levels of anti-HBs antibody among all the patients in the study group, despite the inclusion of HBV vaccination in the national immunization program and proximity to tertiary health-care facilities, underscores the pressing need to reinforce and revise our approach to immunization. High-risk groups, such as ART and STI clinic attendees, solicit further enforcement of accelerated immunization strategies in excess to existing dosing schedules.https://journals.lww.com/10.4103/injms.injms_103_20anti-hbshepatitis bprotective titersyphilis
spellingShingle Bineeta Kashyap
Rituparna Saha
Narendra Pal Singh
Krishna Singha
Protective Antibody Levels Against Hepatitis B among Serodiagnosed Syphilis Cases: Need to Integrate National Control Programs with Immunization Guidelines?
Indian Journal of Medical Specialities
anti-hbs
hepatitis b
protective titer
syphilis
title Protective Antibody Levels Against Hepatitis B among Serodiagnosed Syphilis Cases: Need to Integrate National Control Programs with Immunization Guidelines?
title_full Protective Antibody Levels Against Hepatitis B among Serodiagnosed Syphilis Cases: Need to Integrate National Control Programs with Immunization Guidelines?
title_fullStr Protective Antibody Levels Against Hepatitis B among Serodiagnosed Syphilis Cases: Need to Integrate National Control Programs with Immunization Guidelines?
title_full_unstemmed Protective Antibody Levels Against Hepatitis B among Serodiagnosed Syphilis Cases: Need to Integrate National Control Programs with Immunization Guidelines?
title_short Protective Antibody Levels Against Hepatitis B among Serodiagnosed Syphilis Cases: Need to Integrate National Control Programs with Immunization Guidelines?
title_sort protective antibody levels against hepatitis b among serodiagnosed syphilis cases need to integrate national control programs with immunization guidelines
topic anti-hbs
hepatitis b
protective titer
syphilis
url https://journals.lww.com/10.4103/injms.injms_103_20
work_keys_str_mv AT bineetakashyap protectiveantibodylevelsagainsthepatitisbamongserodiagnosedsyphiliscasesneedtointegratenationalcontrolprogramswithimmunizationguidelines
AT rituparnasaha protectiveantibodylevelsagainsthepatitisbamongserodiagnosedsyphiliscasesneedtointegratenationalcontrolprogramswithimmunizationguidelines
AT narendrapalsingh protectiveantibodylevelsagainsthepatitisbamongserodiagnosedsyphiliscasesneedtointegratenationalcontrolprogramswithimmunizationguidelines
AT krishnasingha protectiveantibodylevelsagainsthepatitisbamongserodiagnosedsyphiliscasesneedtointegratenationalcontrolprogramswithimmunizationguidelines